Ratings St.Shine Optical Co.,Ltd.

Equities

1565

TW0001565000

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
191 ^TWD	+1.06%		+4.09%	+0.53%

Mar. 14	St.Shine Optical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 04	St.Shine Optical Co.,Ltd. Announces Job Adjustment of Chief Information Security Officer	CI

Strengths

Thanks to a sound financial situation, the firm has significant leeway for investment.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

For the past year, analysts have significantly revised downwards their profit estimates.
Most analysts recommend that the stock should be sold or reduced.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ST.SHINE OPTICAL CO.,LTD.	+0.53%	296M		C
ALCON INC.	+22.00%	44.19B		B
THE COOPER COMPANIES, INC.	+2.85%	19.46B		B-
AUTEK CHINA INC.	-16.08%	2.31B		D+
WARBY PARKER INC.	+17.23%	1.92B		C+
PEGAVISION CORPORATION	+27.36%	1.23B		-
MINGYUE OPTICAL LENS CO.,LTD.	-34.93%	755M		-
MENICON CO., LTD.	-40.97%	699M		B-
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-6.32%	677M		-
VIZIONFOCUS INC.	+28.48%	510M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes